|
週次 |
日期 |
單元主題 |
|
第1週 |
09/14 |
A new mouse model Hepatitis B persistence to explore the immune responses |
|
第2週 |
09/21 |
Death domain signaling complexes in innate immunity |
|
第3週 |
09/28 |
Genetic alterations as guides for personalized treatments of leukemia patients |
|
第4週 |
10/05 |
What is vaccine-derived immune memory? How can one measure it? |
|
第5週 |
10/12 |
The role of chromatin modifiers in hypoxia-induced epithelial-mesenchymal transition (EMT) |
|
第6週 |
10/19 |
Maintenance of genome stability and aging |
|
第7週 |
10/26 |
Induction of cancer cells into senescence by telomerase inhibitors |
|
第8週 |
11/02 |
The mode and tempo of virus evolution within and among hosts |
|
第9週 |
11/09 |
Mechanobiology and mechanotransduction in health and disease |
|
第10週 |
11/16 |
Structural basis of type II DNA topoisomerase inhibition by anticancer drugs |
|
第11週 |
11/23 |
Gene-environment interaction in disease causation |
|
第12週 |
11/30 |
Design of integrin-specific drugs |
|
第13週 |
12/07 |
Long-term risk prediction tools of hepatocellular carcinoma for CHB patients |
|
第14週 |
12/14 |
Conflict of interest in medical research |
|
第15週 |
12/21 |
Regulation of hepatitis B virus transcription by sex hormones |
|
第16週 |
12/28 |
Recent advancements in community-acquired Klebsiella liver abscess |